#asth

StockTitan

@stocktitan.net

1 week ago

Healthcare group posts $3.2B sales but flags accounting control flaw Guidance calls for up to $4.1B revenue and $280M adjusted EBITDA in 2026 as Astrana doubles buyback authorization and seeks 15-day 10-K extension.

#ASTH Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results

www.stocktitan.net/news/ASTH/astrana-health...

@cinemalesevigne.bsky.social

4 months ago

Lundi 17 novembre à 20h30 (Tarif : 5€) au Cinéma Le Sévigné :
LE COURAGE EN PLUS
De Billy Touré et Laurent Chevalier
Dans le cadre du festival #festisol et en présence du réalisateur Laurent Chevalier
#lesevigne #Cinema #film #lecourageenplus #aecin #asth #rffr

StockTitan

@stocktitan.net

5 months ago

Astrana Health, Inc. Schedules 2025 Third Quarter Financial Results Release and Conference Call ALHAMBRA, Calif., Oct. 15, 2025/ PRNewswire/-- Astrana Health, Inc., a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2025, after the close of the stock market on...

#ASTH Astrana Health, Inc. Schedules 2025 Third Quarter Financial Results Release and Conference Call

www.stocktitan.net/news/ASTH/astrana-health...

StockTitan

@stocktitan.net

7 months ago

Astrana Health, Inc. Schedules 2025 Second Quarter Financial Results Release and Conference Call Astrana Health (NASDAQ: ASTH), a provider-centric healthcare technology company, has scheduled its Q2 2025 financial results announcement for Thursday, August 7, 2025, after market close.The company will host a conference call at 2:30 PM PT/5:30 PM ET on the same day to discuss the results. Participants can join via phone (877-858-9810 or +1 201-689-8517) or webcast. A slide presentation will be available on the company's IR website, and a recording will be accessible after the call.

#ASTH Astrana Health, Inc. Schedules 2025 Second Quarter Financial Results Release and Conference Call

www.stocktitan.net/news/ASTH/astrana-health...

Small Cap Strategist

@smcapstrategist.bsky.social

9 months ago

Small-cap stocks with declining money flow, Tue Jun 3rd - #YGMZ #SRBK #NTCL #WIMI #TRAW #SOHU #MPB #LX #IMMP #ETCN #CTRM #ASTH #QD #PX #PBT - More: crystalequityresearch.com/SmCpStr/ - #smallcap

StockTitan

@stocktitan.net

10 months ago

Astrana Health, Inc. Reports First Quarter 2025 Results Astrana Health (NASDAQ: ASTH) reported strong Q1 2025 financial results, with total revenue reaching $620.4 million, up 53% year-over-year. Care Partners revenue increased 57% to $601.0 million. However, net income decreased to $6.7 million from $14.8 million, with diluted EPS of $0.14 compared to $0.31 in Q1 2024.The company announced key leadership additions, including Georgie Sam as Chief Data & Analytics Officer and Glenn Sobotka as Chief Accounting Officer. Astrana successfully integrated Collaborative Health Systems and received HSR approval for its pending Prospect Health acquisition. For Q2 2025, the company expects revenue between $615-655 million and adjusted EBITDA of $45-50 million. Full-year 2025 guidance projects revenue of $2.5-2.7 billion and adjusted EBITDA of $170-190 million.

#ASTH Astrana Health, Inc. Reports First Quarter 2025 Results

www.stocktitan.net/news/ASTH/astrana-health...

StockTitan

@stocktitan.net

1 year ago

Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results Astrana Health (NASDAQ: ASTH) reported its Q4 and full-year 2024 financial results, demonstrating significant growth. For FY2024, total revenue reached $2,034.5 million, up 47% year-over-year, with Care Partners revenue increasing 52% to $1,949.0 million. However, net income decreased to $43.1 million from $60.7 million in 2023.Q4 2024 showed mixed results with total revenue up 88% to $665.2 million, but recorded a net loss of $7.0 million compared to income of $12.4 million in Q4 2023. The company secured a new credit agreement with Truist Bank, providing access to $300 million revolving credit, $250 million term loan, and $745 million delayed draw term loan facilities.Recent highlights include a new Care Enablement partnership with Provider HealthLink in Georgia, expected to serve 10,000 Medicare Advantage members. Additionally, eight Astrana affiliates achieved Elite status in APG's 2024 Standards of Excellence survey.

#ASTH Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results

www.stocktitan.net/news/ASTH/astrana-health...

StockTitan

@stocktitan.net

1 year ago

Astrana Health Earnings Alert: Critical Q4 & Full Year Results Coming February 27 - Strategic Updates Expected Astrana Health to unveil Q4 and FY2024 financial performance on February 27. Join management for detailed analysis and strategic insights during earnings call.

#ASTH Astrana Health, Inc. Schedules 2024 Fourth Quarter and Full Year Financial Results Release and Conference Call

www.stocktitan.net/news/ASTH/astrana-health...

StockTitan

@stocktitan.net

1 year ago

Astrana Health Executes $10.5M Share Repurchase from Major Stockholder, Signals Growth Confidence Astrana Health acquires 300,000 shares from Allied Physicians of California at $35.17 per share, demonstrating management's confidence in long-term growth prospects.

#ASTH Astrana Health, Inc. Announces Share Repurchase of 300,000 Shares

www.stocktitan.net/news/ASTH/astrana-health...